K Absolom1, P Holch, B Woroncow, E P Wright, G Velikova. 1. Psychosocial Oncology and Clinical Practice Research Group, St James' Institute of Oncology, University of Leeds, Level 3, Bexley Wing, Beckett Street, Leeds, LS9 7TF, UK, k.l.absolom@leeds.ac.uk.
Abstract
BACKGROUND: In the UK, demonstration of patient and public involvement (PPI) is now a funding requirement. Despite advice being available to researchers regarding PPI, levels of engagement are variable. Patient involvement has been at the core of the Leeds Psychosocial Oncology and Clinical Practice Research Group since 2007 when a local Research Advisory Group (RAG) was established. In addition, we work with experienced patient advocates from national groups. METHODS: The RAG is led by designated researchers who manage and communicate with members. The RAG is invited to twice yearly meetings with the full research team when study findings are disseminated and advice sought. The meetings are also an opportunity to socialise and thank members. Effective partnerships and engagement require good communication, building relationships over time and tailoring involvement to individuals' skills and experience. RESULTS: Patients have been involved in design, planning new projects and assisting with grant proposals; development, pilot testing of interview strategies and question generation, project steering groups and management teams, development of self-management advice for online patient portals; implementation, extensive beta testing of new questionnaire builder software to enable collection of online patient-reported outcomes (PRO) and study websites, cognitive interviews to develop PRO items; dissemination, co-authorship of papers and presentations, attendance/representation of the group at conferences. CONCLUSION: The involvement of patient advocates is integral to ensuring PRO development remains patient-centred. Having a co-operative, well-established local PPI group and nationally active patient collaborators has had a rewarding and significant impact on our research programmes.
BACKGROUND: In the UK, demonstration of patient and public involvement (PPI) is now a funding requirement. Despite advice being available to researchers regarding PPI, levels of engagement are variable. Patient involvement has been at the core of the Leeds Psychosocial Oncology and Clinical Practice Research Group since 2007 when a local Research Advisory Group (RAG) was established. In addition, we work with experienced patient advocates from national groups. METHODS: The RAG is led by designated researchers who manage and communicate with members. The RAG is invited to twice yearly meetings with the full research team when study findings are disseminated and advice sought. The meetings are also an opportunity to socialise and thank members. Effective partnerships and engagement require good communication, building relationships over time and tailoring involvement to individuals' skills and experience. RESULTS: Patients have been involved in design, planning new projects and assisting with grant proposals; development, pilot testing of interview strategies and question generation, project steering groups and management teams, development of self-management advice for online patient portals; implementation, extensive beta testing of new questionnaire builder software to enable collection of online patient-reported outcomes (PRO) and study websites, cognitive interviews to develop PRO items; dissemination, co-authorship of papers and presentations, attendance/representation of the group at conferences. CONCLUSION: The involvement of patient advocates is integral to ensuring PRO development remains patient-centred. Having a co-operative, well-established local PPI group and nationally active patient collaborators has had a rewarding and significant impact on our research programmes.
Authors: Y K Bartlett; D L Selby; A Newsham; A Keding; D Forman; J Brown; G Velikova; P Wright Journal: Eur J Cancer Care (Engl) Date: 2012-04-26 Impact factor: 2.520
Authors: Claire F Snyder; Neil K Aaronson; Ali K Choucair; Thomas E Elliott; Joanne Greenhalgh; Michele Y Halyard; Rachel Hess; Deborah M Miller; Bryce B Reeve; Maria Santana Journal: Qual Life Res Date: 2011-11-03 Impact factor: 4.147
Authors: Diane M Turner-Bowker; Renee N Saris-Baglama; Kevin J Smith; Michael A DeRosa; Christine A Paulsen; Sarah J Hogue Journal: Telemed J E Health Date: 2011-01-07 Impact factor: 3.536
Authors: Elena E Takeuchi; Ada Keding; Noha Awad; Ursula Hofmann; Lyndsay J Campbell; Peter J Selby; Julia M Brown; Galina Velikova Journal: J Clin Oncol Date: 2011-06-20 Impact factor: 44.544
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Laura Ashley; Helen Jones; David Forman; Alex Newsham; Julia Brown; Amy Downing; Galina Velikova; Penny Wright Journal: BMC Med Inform Decis Mak Date: 2011-10-26 Impact factor: 2.796
Authors: Laura Ashley; Helen Jones; James Thomas; Alex Newsham; Amy Downing; Eva Morris; Julia Brown; Galina Velikova; David Forman; Penny Wright Journal: J Med Internet Res Date: 2013-10-25 Impact factor: 5.428
Authors: Jennifer M Poger; Hsin-Chieh Yeh; Cindy L Bryce; Jennifer K Carroll; Lan Kong; Erica B Francis; Jennifer L Kraschnewski Journal: Healthc (Amst) Date: 2019-05-14
Authors: Jeannine M Salamone; Wanda Lucas; Shelley B Brundage; Jamie N Holloway; Sherri M Stahl; Nora E Carbine; Margery London; Naomi Greenwood; Rosa Goyes; Deborah Charles Chisholm; Erin Price; Roberta Carlin; Susan Winarsky; Kirsten B Baker; Julia Maues; Ayesha N Shajahan-Haq Journal: Cancer Res Date: 2018-08-17 Impact factor: 12.701
Authors: Sara J T Guilcher; Sarah Hamilton-Wright; Wayne Skinner; Julia Woodhall-Melnik; Peter Ferentzy; Aklilu Wendaferew; Stephen W Hwang; Flora I Matheson Journal: BMC Health Serv Res Date: 2016-08-02 Impact factor: 2.655
Authors: Lauri Arnstein; Anne Clare Wadsworth; Beverley Anne Yamamoto; Richard Stephens; Kawaldip Sehmi; Rachel Jones; Arabella Sargent; Thomas Gegeny; Karen L Woolley Journal: Res Involv Engagem Date: 2020-06-24
Authors: Kara A Gray-Burrows; Thomas A Willis; Robbie Foy; Martin Rathfelder; Pauline Bland; Allison Chin; Susan Hodgson; Gus Ibegbuna; Graham Prestwich; Kirsty Samuel; Laurence Wood; Farhat Yaqoob; Rosemary R C McEachan Journal: BMJ Qual Saf Date: 2018-04-17 Impact factor: 7.035